Product NDC: | 49643-415 |
Proprietary Name: | Salt Cedar Pollen |
Non Proprietary Name: | Tamarix gallica |
Active Ingredient(s): | 1 g/20mL & nbsp; Tamarix gallica |
Administration Route(s): | CUTANEOUS; INTRADERMAL; SUBCUTANEOUS |
Dosage Form(s): | INJECTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 49643-415 |
Labeler Name: | Allermed Laboratories, Inc. |
Product Type: | NON-STANDARDIZED ALLERGENIC |
FDA Application Number: | BLA102212 |
Marketing Category: | BLA |
Start Marketing Date: | 19740312 |
Package NDC: | 49643-415-50 |
Package Description: | 50 mL in 1 VIAL, MULTI-DOSE (49643-415-50) |
NDC Code | 49643-415-50 |
Proprietary Name | Salt Cedar Pollen |
Package Description | 50 mL in 1 VIAL, MULTI-DOSE (49643-415-50) |
Product NDC | 49643-415 |
Product Type Name | NON-STANDARDIZED ALLERGENIC |
Non Proprietary Name | Tamarix gallica |
Dosage Form Name | INJECTION |
Route Name | CUTANEOUS; INTRADERMAL; SUBCUTANEOUS |
Start Marketing Date | 19740312 |
Marketing Category Name | BLA |
Labeler Name | Allermed Laboratories, Inc. |
Substance Name | TAMARIX GALLICA POLLEN |
Strength Number | 1 |
Strength Unit | g/20mL |
Pharmaceutical Classes | Non-Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [Chemical/Ingredient],Allergens [Chemical/Ingredient],Non-Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [Chemical/Ingredient],Allergens [Chemical/Ingredient] |